Immediate Vs. Delayed Weight Bearing Postoperative Protocol in Diabetic Ankle Fractures
Launched by KYLE SCHWESER MD · May 24, 2019
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the best way for patients with diabetic ankle fractures to recover after surgery. Specifically, it compares two approaches: allowing patients to put weight on their ankle right away using a special brace, versus keeping them off their feet for a longer period. The goal is to see if starting to walk sooner helps with healing, movement, and overall satisfaction, without increasing complications.
To participate in this trial, you need to be an adult (18 years or older) with diabetes and certain types of ankle fractures that require surgery. You should be able to use a brace comfortably and have no major existing ankle problems. Participants can expect to follow a specific protocol after surgery, which includes using the brace and gradually increasing weight on the injured ankle. This study is important because it aims to improve recovery outcomes for people with diabetes who experience ankle fractures, potentially leading to better mobility and quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults 18 and ove
- • 2. Positive for diabetes
- • 3. Positive monofilament test
- • 4. Isolated ankle fracture (non-pilon) and undergoing operative intervention within 3 weeks of fracture
- • 5. Weight less than 275 (124kg)
- • 6. Can tolerate and comply with brace
- • 7. No signs of pre-existing charcot arthroplasty or ankle deformity
- Exclusion Criteria:
- • 1. Children
- • 2. Pregnant patients
- • 3. No signs of diabetes complicated by neuropathy
- • 4. Non-operative ankle fractures
- • 5. Multiple extremity injury
- • 6. Cannot follow post-operative protocol
- • 7. Chronic ankle fractures receiving surgery beyond 3 weeks of injury
About Kyle Schweser Md
Kyle Schweser, MD, is a dedicated physician and clinical trial sponsor with a focus on advancing medical research and improving patient outcomes. With extensive experience in clinical practice and a commitment to evidence-based medicine, Dr. Schweser leads innovative trials aimed at exploring novel therapeutic approaches. His expertise encompasses a range of medical disciplines, and he prioritizes collaboration with regulatory bodies, research institutions, and healthcare professionals to ensure the highest standards of safety and efficacy in clinical studies. Dr. Schweser is passionate about bridging the gap between research and clinical application, fostering advancements that enhance patient care and treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, Missouri, United States
Patients applied
Trial Officials
Kyle M Schweser, MD
Principal Investigator
Assistant Professor Orthopaedic Trauma/Foot and Ankle
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials